Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Merli

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Oncology|September 18, 2017
Systemic Inflammatory Response Is a Prognostic Marker in HIV-Infected Patients with Hepatocellular CarcinomaDavid J Pinato, Marco Merli, Alessia Dalla Pria, et al.
Plos One|August 2, 2017
Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patientsNicola Gianotti, Andrea Poli, Laura Galli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 1, 2022
Similar survival but higher and delayed hepatocellular carcinoma recurrence in HIV-positive compared to negative cirrhotics undergoing liver transplantationRoberto Rossotti, Marco Merli, Chiara Mazzarelli, et al.
Journal of Viral Hepatitis|February 26, 2019
The impact of HIV infection and men who have sex with men status on hepatitis A infection: The experience of two tertiary centres in Northern Italy during the 2017 outbreak and in the 2009-2016 periodAndrea Lombardi, Roberto Rossotti, Maria Cristina Moioli, et al.
The New Microbiologica|May 20, 2016
Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patientsMarco Merli, Laura Galli, Antonella Castagna, et al.
Plos One|August 1, 2017
Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patientsCaterina Sagnelli, Caterina Uberti-Foppa, Hamid Hasson, et al.
Internal and Emergency Medicine|July 13, 2024
Bloodstream infections due to multi-drug resistant bacteria in the emergency department: prevalence, risk factors and outcomes-a retrospective observational studyNicolò Capsoni, Giulia Maria Azin, Marida Scarnera, et al.
European Journal of Clinical Investigation|December 27, 2021
Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: The X-COVID-19 Randomized TrialNuccia Morici, GianMarco Podda, Simone Birocchi, et al.
Sexual Health|July 1, 2026
Non-occupational post-exposure prophylaxis does not expand or differentiate candidates for pre-exposure prophylaxisNicholas Brian Bana, Leonardo Francesco Rezzonico, Gabriele Cavazza, et al.
World Journal of Gastroenterology|October 28, 2016
TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotypeCaterina Sagnelli, Marco Merli, Caterina Uberti-Foppa, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Oncology|September 18, 2017
Systemic Inflammatory Response Is a Prognostic Marker in HIV-Infected Patients with Hepatocellular CarcinomaDavid J Pinato, Marco Merli, Alessia Dalla Pria, et al.
Plos One|August 2, 2017
Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patientsNicola Gianotti, Andrea Poli, Laura Galli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 1, 2022
Similar survival but higher and delayed hepatocellular carcinoma recurrence in HIV-positive compared to negative cirrhotics undergoing liver transplantationRoberto Rossotti, Marco Merli, Chiara Mazzarelli, et al.
Journal of Viral Hepatitis|February 26, 2019
The impact of HIV infection and men who have sex with men status on hepatitis A infection: The experience of two tertiary centres in Northern Italy during the 2017 outbreak and in the 2009-2016 periodAndrea Lombardi, Roberto Rossotti, Maria Cristina Moioli, et al.
The New Microbiologica|May 20, 2016
Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patientsMarco Merli, Laura Galli, Antonella Castagna, et al.
Plos One|August 1, 2017
Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patientsCaterina Sagnelli, Caterina Uberti-Foppa, Hamid Hasson, et al.
Internal and Emergency Medicine|July 13, 2024
Bloodstream infections due to multi-drug resistant bacteria in the emergency department: prevalence, risk factors and outcomes-a retrospective observational studyNicolò Capsoni, Giulia Maria Azin, Marida Scarnera, et al.
European Journal of Clinical Investigation|December 27, 2021
Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: The X-COVID-19 Randomized TrialNuccia Morici, GianMarco Podda, Simone Birocchi, et al.
Sexual Health|July 1, 2026
Non-occupational post-exposure prophylaxis does not expand or differentiate candidates for pre-exposure prophylaxisNicholas Brian Bana, Leonardo Francesco Rezzonico, Gabriele Cavazza, et al.
World Journal of Gastroenterology|October 28, 2016
TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotypeCaterina Sagnelli, Marco Merli, Caterina Uberti-Foppa, et al.
Pageof 9